ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Dopamine Uptake Inhibitors

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Neurotransmitter Agents ∟ Dopamine Agents ∟ Dopamine Uptake Inhibitors 4 coordinate concepts ∟ Adrenergic Uptake Inhibitors \| ∟ Serotonin Uptake Inhibitors \| ∟ Dopamine Agonists \| ∟ Dopamine Antagonists Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors ∟ Dopamine Uptake Inhibitors 4 coordinate concepts ∟ Adrenergic Uptake Inhibitors \| ∟ Serotonin Uptake Inhibitors \| ∟ Dopamine Agonists \| ∟ Dopamine Antagonists Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Neurotransmitter Agents ∟ Dopamine Agents ∟ Dopamine Uptake Inhibitors 4 coordinate concepts ∟ Adrenergic Uptake Inhibitors \| ∟ Serotonin Uptake Inhibitors \| ∟ Dopamine Agonists \| ∟ Dopamine Antagonists Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors ∟ Dopamine Uptake Inhibitors 4 coordinate concepts ∟ Adrenergic Uptake Inhibitors \| ∟ Serotonin Uptake Inhibitors \| ∟ Dopamine Agonists \| ∟ Dopamine Antagonists X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Neurotransmitter Agents ∟ Dopamine Agents ∟ Dopamine Uptake Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors ∟ Dopamine Uptake Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Neurotransmitter Agents ∟ Dopamine Agents ∟ Dopamine Uptake Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors ∟ Dopamine Uptake Inhibitors Dopamine Agents > Neurotransmitter Agents > Molecular Mechanisms of Action > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Neurotransmitter Uptake Inhibitors > Neurotransmitter Agents > Molecular Mechanisms of Action > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Dopamine Agents > Neurotransmitter Agents > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Neurotransmitter Uptake Inhibitors > Neurotransmitter Agents > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Annotation:	GEN or unspecified; prefer specifics; DF: DOPAMINE UPTAKE INHIB X
History note:	Dopamine Agents (1989-1994) \| Neurotransmitter Uptake Inhibitors (1985-1994)X
historyNote*:	95 X
publicMeSHNote*:	95 X
Scope note:	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1994-06-01X
dateEstablished*:	1995-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	TPWX
Type:	Concept X
Coordinate terms:	Adrenergic Uptake Inhibitors \| Serotonin Uptake Inhibitors \| Dopamine Agonists \| Dopamine Antagonists X
URI:	X
Labels and equivalent concepts:	Dopamiinin takaisinoton estäjät (fi) Dopamiinin takaisinoton estäjä (fi, replaced) Dopamiinin takaisinoton inhibiittori (fi, replaced) Dopamiinin takaisinoton inhibiittorit (fi, replaced) Dopaminupptagshämmare (sv) Uptake Inhibitors, Dopamine (en, replaced) Reuptake Inhibitors, Dopamine (en, replaced) Inhibitors, Dopamine Reuptake (en, replaced) Inhibitors, Dopamine Uptake (en, replaced) Dopamine Reuptake Inhibitors (en, replaced) X
Share:	X